Stay updated on Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page.

Latest updates to the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page shows Revision: v3.4.1, replacing v3.4.0; no changes to study content or functionality are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThese changes are limited to UI and metadata, including a glossary option, minor capitalization/wording in QC labels, and revision/version information, with no impact on core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, indicating a minor maintenance update. No changes to the study details or user-facing content were observed.SummaryDifference0.1%

- Check63 days agoChange DetectedDifference0.2%

- Check92 days agoChange DetectedThe page shows an internal revision tag updated from v3.2.0 to v3.3.2; no changes to the study details, eligibility criteria, outcomes, or location information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page.